| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |